Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2026-01-01 @ 2:21 PM
Study NCT ID:
NCT04502966
Status:
COMPLETED
Last Update Posted:
2025-07-15
First Post:
2020-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-04
First Submit QC Date:
None
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-10
Last Update Post Date:
2025-07-15
Last Update Post Date Type:
ACTUAL